[Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006]. 2010

Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
Developmental Research Laboratories, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.

The activity of antibacterial agents against aerobic Gram-positive cocci (26 species, 1022 strains) and anaerobic bacteria (23 species, 184 strains) isolated from clinical specimens in 2006 at 16 clinical facilities in Japan were studied using either broth microdilution or agar dilution method. The ratio of methicillin-resistant strains among Staphylococcus aureus and Staphylococcus epidermidis was 53.0% and 65.8%, suggesting that resistant strains were isolated at high frequency. Vancomycin (VCM) and quinupristin/dalfopristin (QPR/DPR) had good antibacterial activity against methicillin-resistant S. aureus and methicillin-resistant S. epidermidis, with MIC90s of < or = 2 micrcog/mL. The ratio of penicillin (PC) intermediate and resistant strains classified by mutations of PC-binding proteins among Streptococcus pneumoniae was 87.6%. Ceftriaxone, cefpirome, cefepime, carbapenem antibiotics, VCM, teicoplanin, linezolid(LZD) and QPR/DPR had MIC90s of < or = 1 microg/mL against PC-intermediate and resistant S. pneumoniae strains. Against all strains of Enterococcus faecalis and Enterococcus faecium, the MICs of VCM and TEIC were under 2 microg/mL, and no resistant strain was detected, suggesting that these agents had excellent activities against these species. 10.9% of E. faecalis strains or 3.5% of E. faecium strains showed intermediate or resistant to LZD. 24.4% of E. faecium strains showed intermediate or resistant to QPR/DPR. Against all strains of Clostridium difficile, the MIC of VCM were under 1 microg/mL, suggesting that VCM had excellent activity against C. difficile. Carbapenems showed good activity against Peptococcaceae, Bacteroides spp., and Prevotella spp. However since several strains of Bacteroides fragilis showed resistant to carbapenems and the susceptibility of this species should be well-focused in the future.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010460 Peptococcus A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of the mouth, upper respiratory tract, and large intestine in humans. Its organisms cause infections of soft tissues and bacteremias.
D006095 Gram-Positive Cocci Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram's method. Gram Positive Cocci
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001420 Bacteria, Aerobic Bacteria which require oxygen in order to grow and survive. Aerobic Bacteria
D001421 Bacteria, Anaerobic Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen. Anaerobic Bacteria
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D013291 Streptococcus A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.
D016983 Enterococcus A genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus.

Related Publications

Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
April 2008, International journal of antimicrobial agents,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
June 1984, European journal of clinical microbiology,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
January 1998, Clinical microbiology reviews,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
May 1994, The Journal of antimicrobial chemotherapy,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
August 1988, The Journal of surgical research,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
July 2020, Mikrobiyoloji bulteni,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
August 2021, Microorganisms,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
April 1972, Mayo Clinic proceedings,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
August 1984, Infection and immunity,
Takahiro Yamaguchi, and Isamu Yoshida, and Yoshihisa Itoh, and Mineji Tachibana, and Choichiro Takahashi, and Mitsuo Kaku, and Keiji Kanemitsu, and Masahiko Okada, and Yoshinori Horikawa, and Joji Shiotani, and Hiroyoshi Kino, and Yuka Ono, and Hisashi Baba, and Shuji Matsuo, and Seishi Asari, and Masahiro Toyokawa, and Kimiko Matsuoka, and Nobuchika Kusano, and Motoko Nose, and Mitsuharu Murase, and Hitoshi Miyamoto, and Tetsunori Saikawa, and Kazufumi Hiramatsu, and Shigeru Kohno, and Katsunori Yanagihara, and Nobuhisa Yamane, and Isamu Nakasone, and Hideki Maki, and Yoshinori Yamano
January 1991, Diagnostic microbiology and infectious disease,
Copied contents to your clipboard!